It has been shown that patients with TNBC and high OSM expression have a greater abundance of cells with a cancer stem cell (CSC) phenotype due to OSM/STAT3/SMAD3 signaling, which promotes growth of the tumor and leads to poor clinical outcomes for patients (111, 124). This evidence concerns the gene STAT3 and cancer.